Want to see ENDV full AI Analyst Report?

Endonovo Therapeutics (ENDV) Revenue

24 Followers

Endonovo Therapeutics Revenue

Endonovo Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Endonovo Therapeutics had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

0.00

Revenue Growth

-100.00%

P/S Ratio

―

Revenue/Employee

Employees

Market Cap

$180.76K

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-10.04K	-100.00%
Dec 31, 2024	10.04K	-130.20K	-92.84%
Dec 31, 2023	140.24K	4.89K	+3.61%
Dec 31, 2022	135.35K	62.25K	+85.15%
Mar 31, 2022	73.11K	-92.69K	-55.91%
Mar 31, 2021	165.80K	-144.37K	-46.55%
Mar 31, 2020	310.16K	226.90K	+272.51%
Dec 31, 2018	83.26K	―	+∞%
Dec 31, 2017	―	―	―